Menu

AB Cube’s SafetyEasy® Suite cloud-based multivigilance software successfully passes China ICH E2B (R3) testing

Leading drug safety database software successfully passes ICSR testing in key China market and is now available – in local language – for all customers

Paris, France, July 26 2023 – AB Cube, innovator of trusted cloud software for life science multivigilance, today announces that its ICH E2B (R3)-compliant multivigilance software SafetyEasy® Suite has successfully passed testing in China for the electronic transmission of individual case safety reports (ICSRs).  The industry-leading SafetyEasy® solution completed ICH E2B (R3) testing in China for a major Contract Research Organisation customer, and has now been integrated – in local language – into AB Cube’s market-leading software suite.

The SafetyEasy® solution is now in general availability for all life science organisations who are developing, manufacturing and marketing regulated products in the China market. China is currently the second largest pharmaceutical market in the world, with strong growth predicted over the next decade and a projected market value of US$575B for 20221.

Since 1st July 2022, it has been mandatory for pharmaceutical manufacturers operating in China to submit all post-marketing Adverse Drug Reaction reports in the ICH E2B R3 format adopted by the Chinese regulatory authorities. The ICH E2B (R3) guideline outlines the key requirements for electronic transmission of ICSRs, and provides specifications on mandated data elements for safety report submissions – from the clinical trial phase through to post-authorisation.

Commenting on the new availability of the SafetyEasy® solution for the China market, Matthieu Doresse, Founder & CEO of AB Cube said: “Following successful testing and confirmation of our full compliance with China’s E2B(R3) guidelines, we are delighted to now be offering our SafetyEasy® Suite solution to customers with complete localisation capabilities. We look forward to bringing the benefits of our agile safety software to life science organisations of all sizes who are engaged in this region.”

SafetyEasy® Suite delivers cost-effective drug safety database software for E2B(R3) pharmacovigilance compliance, medical device vigilance, cosmetovigilance and nutrivigilance. SafetyEasy® Suite aligns international vigilance operations across all product types to provide comprehensive multivigilance reporting – from intake to safety signals – in a single, secure and reliable software solution. Offering seamless integration with existing IT environments, the cloud-based SaaS SafetyEasy® Suite solution allows teams to collaborate globally for case management.

1. Statista, Pharmaceutical market value in China in 2016 and 2022.

Ends---

About AB Cube http://www.ab-cube.com)
AB Cube provides the most cost-effective drug safety database software for E2B(R3) pharmacovigilance compliance, medical device vigilance, cosmetovigilance, veterinary pharmacovigilance and nutrivigilance. The pioneer of the industry’s first Software-as-a-Service pharmacovigilance software in 2006, today Clinical Service Organisations, Contract Research Organisations and Marketing Authorisation Holders worldwide trust AB Cube’s reliable and proven SafetyEasy® Suite software to meet their global multivigilance needs at every scale – from one to 1 million cases.

AB Cube’s SafetyEasy® Suite multivigilance solution delivers a truly unified, cloud-based solution for global life science companies – integrating intelligent automation to transform adverse event reporting and boost compliance. SafetyEasy® Suite integrates AI with existing drug safety processes, ensuring smooth management of adverse event reporting and optimising regulatory compliance.

AB Cube announces that its ICH E2B (R3)-compliant multivigilance software SafetyEasy® Suite has successfully passed testing in China for the electronic transmission of individual case safety reports (ICSRs).  
AB Cube announces that its ICH E2B (R3)-compliant multivigilance software SafetyEasy® Suite has successfully passed testing in China for the electronic transmission of individual case safety reports (ICSRs).  

News Release Index

14th December 2023 - DnaNudge
DnaNudge secures FDA approval to deploy a Multiplex PCR platform for diagnosing four-in-one respiratory pathogens in Ghana

6th November 2023 - DnaNudge
NantNudge and DnaNudge Launch a Revolutionary Genomic Handheld Device, with First-Of-Kind Point-Of-Decision, Lab in Cartridge PCR Test

26th July 2023 - AB Cube
AB Cube’s SafetyEasy® Suite cloud-based multivigilance software successfully passes China ICH E2B (R3) testing

13th March 2023 - DnaNudge
DnaNudge forges strategic partnership with Mylab Discovery Solutions to deliver next-generation point-of-decision diagnostics for diabetic foot infections

14th February 2023 - DnaNudge
DnaNudge in pilot with Holland & Barrett: Nutrition and Skincare genetics services now available at leading wellness retailer’s flagship London store

30th November 2022 - Diagnostics for the Real World
Diagnostics for the Real World’s landmark SAMBA machine enters Science Museum Group’s permanent collection and features in major new “Injecting Hope” exhibition

5th October 2022 - Diagnostics for the Real World
Diagnostics for the Real World’s multiplex respiratory virus rapid point-of-care tests approved for sale in New Zealand  

8th July 2022 - EPSRC UK-RAS Network
EPSRC UK-RAS Network Launches Key Whitepaper On State-of-the-Art In Legged Robotics  

17th June 2022 - EPSRC UK-RAS Network
National poll: third of Brits open to trialling the use of robots

26th May 2022 - EPSRC UK-RAS Network
Get Ready for UK Festival of Robotics 2022 (18th-24th June): join the conversation as UK robotics labs open doors to the public

18th May 2022 - Diagnostics for the Real World
Diagnostics for the Real World (DRW) achieves UK technical validation for two multiplex respiratory virus rapid tests

13th May 2022 - EPSRC UK-RAS Network
Robot Lab Live returns for UK Festival of Robotics 2022:  join UK’s top robotics research labs for exclusive live demos – Wednesday June 22nd, 4-6pm BST, UK Robotics YouTube Channel

22nd March 2022 - White City Innovation District
London’s global innovation hub: official launch of White City Innovation District

14th March 2022 - Professor Chris Toumazou
Regius Professor Chris Toumazou named first ever UK winner of the UNESCO-Equatorial Guinea International Prize for Research in the Life Sciences

2nd February 2022 - pharmasol
pharmasol completes merger with PharmaLex Group

11th January 2022 - Hamlyn Centre
Ready, set, robot! National Robot Drawing and Story Competitions for Primary Schoolchildren Now Officially Open For Entries

chat_bubble

Hello. Question about our services and how we can help? Please leave us a message and we will get back to you soon. Thanks.